Using Ribonucleoprotein-based CRISPR/Cas9 to edit single nucleotide on human induced pluripotent stem cells to model type 3 long QT syndrome (SCN5A+/-)
Ning Ge(Ollscoil na Gaillimhe – University of Galway), Terence Prendiville(Children's Health Ireland at Crumlin)
Cited by 0
Related Papers
Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)
|JAMA Cardiology|2019|248
Hsa_circ_0007142 contributes to cisplatin resistance in esophageal squamous cell carcinoma via miR‐494‐3p/LASP1 axis
|Journal of Clinical Laboratory Analysis|2022|21